Robert L. Roden

3.2k total citations
23 papers, 2.5k citations indexed

About

Robert L. Roden is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pharmacology. According to data from OpenAlex, Robert L. Roden has authored 23 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 10 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Robert L. Roden's work include Heart Failure Treatment and Management (6 papers), Receptor Mechanisms and Signaling (6 papers) and Cardiomyopathy and Myosin Studies (4 papers). Robert L. Roden is often cited by papers focused on Heart Failure Treatment and Management (6 papers), Receptor Mechanisms and Signaling (6 papers) and Cardiomyopathy and Myosin Studies (4 papers). Robert L. Roden collaborates with scholars based in United States and Italy. Robert L. Roden's co-authors include Michael R. Bristow, Wayne Minobe, J. David Port, William T. Abraham, Kōichi Nakao, Leslie A. Leinwand, Brian D. Lowes, Darrin Dutcher, Teresa Bohlmeyer and Bertron Μ. Groves and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Journal of the American College of Cardiology.

In The Last Decade

Robert L. Roden

23 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert L. Roden United States	17	1.8k	1.2k	263	232	219	23	2.5k
Leonard G. Meggs United States	26	1.7k 0.9×	1.3k 1.1×	352 1.3×	453 2.0×	327 1.5×	60	3.1k
Chester H. Conrad United States	23	1.5k 0.8×	816 0.7×	251 1.0×	141 0.6×	263 1.2×	45	2.2k
Christian Holubarsch Germany	22	1.8k 1.0×	1.0k 0.9×	279 1.1×	73 0.3×	195 0.9×	46	2.6k
Tiziana Bachetti Italy	23	1.1k 0.6×	857 0.7×	202 0.8×	245 1.1×	545 2.5×	56	2.5k
Guido Boerrigter United States	30	1.8k 1.0×	758 0.6×	336 1.3×	268 1.2×	249 1.1×	77	2.7k
Irene L. Ennis Argentina	30	1.2k 0.7×	1.4k 1.2×	197 0.7×	262 1.1×	327 1.5×	76	2.2k
Takahisa Noma Japan	26	1.1k 0.6×	877 0.7×	333 1.3×	303 1.3×	351 1.6×	91	2.3k
Hisashi Fukuzaki Japan	22	769 0.4×	728 0.6×	401 1.5×	191 0.8×	450 2.1×	147	2.1k
N. C. Trippodo United States	27	1.3k 0.7×	595 0.5×	180 0.7×	343 1.5×	410 1.9×	58	2.2k
Frank R. Heinzel Germany	31	1.7k 0.9×	1.1k 0.9×	183 0.7×	156 0.7×	214 1.0×	89	2.5k

Countries citing papers authored by Robert L. Roden

Since Specialization

Citations

This map shows the geographic impact of Robert L. Roden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert L. Roden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert L. Roden more than expected).

Fields of papers citing papers by Robert L. Roden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert L. Roden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert L. Roden. The network helps show where Robert L. Roden may publish in the future.

Co-authorship network of co-authors of Robert L. Roden

This figure shows the co-authorship network connecting the top 25 collaborators of Robert L. Roden. A scholar is included among the top collaborators of Robert L. Roden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert L. Roden. Robert L. Roden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Black, Henry R., George L. Bakris, Michael A. Weber, et al.. (2007). Efficacy and Safety of Darusentan in Patients With Resistant Hypertension: Results From a Randomized, Double‐Blind, Placebo‐Controlled Dose‐Ranging Study. Journal of Clinical Hypertension. 9(10). 760–769. 77 indexed citations

Abraham, William T., Mary V. Raynolds, David B. Badesch, et al.. (2003). Angiotensin-converting enzyme DD genotype in patients with primary pulmonary hypertension: increased frequency and association with preserved haemodynamics. Journal of the Renin-Angiotensin-Aldosterone System. 4(1). 27–30. 56 indexed citations

Asano, Koji, Teresa Bohlmeyer, Jay Y. Westcott, et al.. (2002). Altered Expression of Endothelin Receptors in Failing Human Left Ventricles. Journal of Molecular and Cellular Cardiology. 34(7). 833–846. 27 indexed citations

Abraham, William T., Edward M. Gilbert, Brian D. Lowes, et al.. (2002). Coordinate Changes in Myosin Heavy Chain Isoform Gene Expression Are Selectively Associated With Alterations in Dilated Cardiomyopathy Phenotype. Molecular Medicine. 8(11). 750–760. 79 indexed citations

Lowes, Brian D., Michael B. Higginbotham, Marcus A. DeWood, et al.. (2000). Low-dose enoximone improves exercise capacity in chronic heart failure∗∗A list of the Enoximone Study Group Members and institutional affiliations is provided in the appendix.. Journal of the American College of Cardiology. 36(2). 501–508. 37 indexed citations

Bisognano, John D., Howard D. Weinberger, Teresa Bohlmeyer, et al.. (2000). Myocardial-Directed Overexpression of the Human β1-Adrenergic Receptor in Transgenic Mice. Journal of Molecular and Cellular Cardiology. 32(5). 817–830. 205 indexed citations

Bowling, Nancy, Richard A. Walsh, Guojie Song, et al.. (1999). Increased Protein Kinase C Activity and Expression of Ca ²⁺ -Sensitive Isoforms in the Failing Human Heart. Circulation. 99(3). 384–391. 392 indexed citations

Bristow, Michael R., et al.. (1998). The role of third-generation beta-blocking agents in chronic heart failure. Clinical Cardiology. 21(S1). I3–I13. 60 indexed citations

Lowes, Brian D., Wayne Minobe, William T. Abraham, et al.. (1997). Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium.. Journal of Clinical Investigation. 100(9). 2315–2324. 382 indexed citations

10.

Asano, Koji, Darrin Dutcher, J. David Port, et al.. (1997). Selective Downregulation of the Angiotensin II AT₁-Receptor Subtype in Failing Human Ventricular Myocardium. Circulation. 95(5). 1193–1200. 139 indexed citations

11.

Nakao, Kōichi, Wayne Minobe, Robert L. Roden, Michael R. Bristow, & Leslie A. Leinwand. (1997). Myosin heavy chain gene expression in human heart failure.. Journal of Clinical Investigation. 100(9). 2362–2370. 327 indexed citations

12.

Yoshikawa, Tsutomu, J. David Port, Koji Asano, et al.. (1996). Cardiac adrenergic receptor effects of carvedilol. European Heart Journal. 17(suppl B). 8–16. 146 indexed citations

13.

Focaccio, Amelia, G Peeters, Matthew A. Movsesian, et al.. (1996). Mechanism of Action of OPC-8490 in Human Ventricular Myocardium. Circulation. 93(4). 817–825. 9 indexed citations

14.

Zisman, Lawrence S., William T. Abraham, Brian D. Lowes, et al.. (1995). 757-2 Angiotensin II Formation in the Intact Human Heart: Predominance of the Angiotensin Converting Enzyme Pathway. Journal of the American College of Cardiology. 25(2). 234A–235A. 1 indexed citations

15.

Zisman, Lawrence S., William T. Abraham, Robert A. Quaife, et al.. (1995). Angiotensin II formation in the intact human heart. Predominance of the angiotensin-converting enzyme pathway.. Journal of Clinical Investigation. 96(3). 1490–1498. 98 indexed citations

16.

Asano, Koji, Wayne Minobe, Darrin Dutcher, et al.. (1995). 776-1 Selective Down-regulation of Angiotensin II AT 1 Receptors in Failing Human Heart: Relationship to β 1 -Receptor Down-regulation. Journal of the American College of Cardiology. 25(2). 291A–292A. 4 indexed citations

17.

Bristow, Michael R., Patti Larrabee, Wayne Minobe, et al.. (1992). Receptor Pharmacology of Carvedilol in the Human Heart. Journal of Cardiovascular Pharmacology. 19(Supplement 1). S68–S80. 76 indexed citations

18.

Bristow, Michael R., et al.. (1992). Effects of carvedilol on adrenergic receptor pharmacology in human ventricular myocardium and lymphocytes. Journal of Molecular Medicine. 70(S2). S105–13. 44 indexed citations

19.

Donahue, S.P., Arthur W. English, Robert L. Roden, & Gail Schwartz. (1991). Tenotomy delays both synapse elimination and myogenesis in rat lateral gastrocnemius. Neuroscience. 42(1). 275–282. 5 indexed citations

20.

Roden, Robert L., S.P. Donahue, Gail Schwartz, John G. Wood, & Arthur W. English. (1991). 200 kD neurofilament protein and synapse elimination in the rat soleus muscle. Synapse. 9(4). 239–243. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact